Literature DB >> 24656611

Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.

Venumadhav Janganati1, Narsimha Reddy Penthala1, Chad E Cragle2, Angus M MacNicol3, Peter A Crooks4.   

Abstract

Aminoparthenolide derivatives have been prepared by reaction of parthenolide with various heterocyclic amines to afford corresponding Michael addition products. These novel compounds were evaluated for their modulatory effects on Xenopus oocyte maturation. Two compounds, 6e and 6f, were identified that promote G2-M cell cycle progression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Heterocyclic amines; Michael addition; Oocyte maturation; Parthenolide; Progesterone

Mesh:

Substances:

Year:  2014        PMID: 24656611      PMCID: PMC4121966          DOI: 10.1016/j.bmcl.2014.02.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  42 in total

Review 1.  Xenopus oocyte maturation: new lessons from a good egg.

Authors:  J E Ferrell
Journal:  Bioessays       Date:  1999-10       Impact factor: 4.345

2.  The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

Authors:  Monica L Guzman; Randall M Rossi; Lilliana Karnischky; Xiaojie Li; Derick R Peterson; Dianna S Howard; Craig T Jordan
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

3.  Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

Authors:  Michele T Yip-Schneider; Harikrishna Nakshatri; Christopher J Sweeney; Mark S Marshall; Eric A Wiebke; C Max Schmidt
Journal:  Mol Cancer Ther       Date:  2005-04       Impact factor: 6.261

4.  Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta.

Authors:  S P Hehner; M Heinrich; P M Bork; M Vogt; F Ratter; V Lehmann; K Schulze-Osthoff; W Dröge; M L Schmitz
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Feverfew: weeding out the root of leukaemia.

Authors:  Monica L Guzman; Craig T Jordan
Journal:  Expert Opin Biol Ther       Date:  2005-09       Impact factor: 4.388

6.  The mitogen-activated protein kinase signaling pathway stimulates mos mRNA cytoplasmic polyadenylation during Xenopus oocyte maturation.

Authors:  E L Howard; A Charlesworth; J Welk; A M MacNicol
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 7.  Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus.

Authors:  Grant N Wheeler; André W Brändli
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

8.  Antileukemic activity of aminoparthenolide analogs.

Authors:  Shama Nasim; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-06-19       Impact factor: 2.823

9.  A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex.

Authors:  Aude Dupré; Louise Boyer-Chatenet; Rose M Sattler; Ami P Modi; Ji-Hoon Lee; Matthew L Nicolette; Levy Kopelovich; Maria Jasin; Richard Baer; Tanya T Paull; Jean Gautier
Journal:  Nat Chem Biol       Date:  2008-01-06       Impact factor: 15.040

10.  MAPK interacts with XGef and is required for CPEB activation during meiosis in Xenopus oocytes.

Authors:  Brian T Keady; Peiwen Kuo; Susana E Martínez; Lei Yuan; Laura E Hake
Journal:  J Cell Sci       Date:  2007-03-15       Impact factor: 5.285

View more
  2 in total

1.  Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.

Authors:  Narsimha R Penthala; Shobanbabu Bommagani; Venumadhav Janganati; Kenzie B MacNicol; Chad E Cragle; Nikhil R Madadi; Linda L Hardy; Angus M MacNicol; Peter A Crooks
Journal:  Eur J Med Chem       Date:  2014-08-07       Impact factor: 6.514

2.  Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.

Authors:  Venumadhav Janganati; Jessica Ponder; Craig T Jordan; Michael J Borrelli; Narsimha Reddy Penthala; Peter A Crooks
Journal:  J Med Chem       Date:  2015-11-16       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.